Latest BDX reports update at 2024-02-01: 2023-Q4 ∙ 2022-Q4
  1. Home
  2. Stock quotes
  3. Stock Becton, Dickinson and Company
Becton, Dickinson and Company logo

Becton, Dickinson and Company BDX

$ 231.55 0.46%
mail-toReport an Error

Country

 usaUSA

IPO year

 -

Industry

 Medical instruments

Stock Exchange

 NYSESPB

CEO

 Mr. Thomas Polen

Employees in the company

 72 000

Shares

 286 M

Market Cap[1]

 $ 66.3 B

EBITDA (LTM)

 $ 4.06 B

P/E (LTM)

 43.06

P/S (LTM)

 3.63

EPS (LTM)

 5.59

Becton, Dickinson and Company is an international company specializing in the development and production of medical devices and technologies for the diagnosis and treatment of various diseases. The company was founded in 1897 in the United States and today is one of the largest manufacturers of medical devices in the world.

BDX offers a wide range of medical devices, including syringes, needles, blood collection systems, microbiological and diagnostic systems, and more. The company also provides training for healthcare professionals, consultations, and support for patients.

The company has offices worldwide and serves patients in more than 190 countries. The headquarters are located in New Jersey, USA.

Becton, Dickinson and Company's goal is to help people lead healthy lifestyles by providing them with innovative medical devices and technologies. The company actively works on developing new products and improving the quality of its services to meet the needs of its customers.

Other stocks of industry "Medical instruments"

Issuer Price % 24h Market Cap Exchange Country
Hill-Rom Holdings, Inc. Hill-Rom Holdings, Inc.
HRC
 		$ 155.68 -0.05 % $ 10.3 B NYSE,SPB usaUSA
LeMaitre Vascular LeMaitre Vascular
LMAT
 		$ 65.46 3.92 % $ 1.45 B Nasdaq Global Market,SPB usaUSA
Repligen Corporation Repligen Corporation
RGEN
 		$ 166.58 0.56 % $ 9.28 M Nasdaq Global Select Market,SPB usaUSA
BioLife Solutions BioLife Solutions
BLFS
 		$ 17.53 3.97 % $ 766 M Nasdaq Global Select Market usaUSA
Teleflex Incorporated Teleflex Incorporated
TFX
 		$ 206.71 - $ 9.71 B NYSE,SPB usaUSA
Utah Medical Products Utah Medical Products
UTMD
 		$ 65.92 -0.56 % $ 239 M Nasdaq Global Select Market usaUSA
electroCore electroCore
ECOR
 		$ 5.33 -6.49 % $ 25.3 M Nasdaq Global Select Market usaUSA
Akers Biosciences, Inc. Akers Biosciences, Inc.
AKER
 		$ 2.47 -9.52 % $ 20.6 M Nasdaq Capital Market usaUSA
Apria, Inc. Apria, Inc.
APR
 		$ 37.5 - $ 1.34 B Nasdaq Global Select Market usaUSA
Antares Pharma, Inc. Antares Pharma, Inc.
ATRS
 		$ 5.59 - $ 955 M Nasdaq Capital Market usaUSA
Cantel Medical Corp. Cantel Medical Corp.
CMD
 		$ 80.37 -1.18 % $ 3.4 B NYSE usaUSA
CRH Medical Corporation CRH Medical Corporation
CRHM
 		$ 3.99 - $ 282 M NYSE American -
IntriCon Corporation IntriCon Corporation
IIN
 		$ 24.24 0.04 % $ 225 M Nasdaq Global Select Market usaUSA
Luminex Corporation Luminex Corporation
LMNX
 		$ 36.99 - $ 1.75 B Nasdaq Global Select Market usaUSA
Varian Medical Systems, Inc. Varian Medical Systems, Inc.
VAR
 		$ 177.07 -0.02 % $ 16.3 B NYSE usaUSA
Isoray Isoray
ISR
 		$ 0.38 0.03 % $ 108 M NYSE American usaUSA
Harvard Bioscience Harvard Bioscience
HBIO
 		$ 3.62 1.69 % $ 154 M Nasdaq Global Market usaUSA
AtriCure AtriCure
ATRC
 		$ 23.17 2.48 % $ 1.07 B Nasdaq Global Market,SPB usaUSA
Intuitive Surgical Intuitive Surgical
ISRG
 		$ 375.33 0.59 % $ 132 B Nasdaq Global Select Market,SPB usaUSA
Pro-Dex Pro-Dex
PDEX
 		$ 18.68 1.19 % $ 66.7 M Nasdaq Global Select Market usaUSA

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.